Liver cancer patients get Pre-Surgery combo: radiation plus immunotherapy shows promise
NCT ID NCT04857684
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving a short course of targeted radiation (SBRT) along with two immunotherapy drugs (atezolizumab and bevacizumab) before surgery is safe and effective for people with liver cancer that can be removed. About 20 participants will receive this combination, then undergo surgery. The main goal is to check for serious side effects, while also seeing how well the tumors shrink and how many surgeries are successful.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESECTABLE HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114, United States